Supplementary Figures 1-8 from Polycomb-like Protein 3 Induces Proliferation and Drug Resistance in Multiple Myeloma and Is Regulated by miRNA-15a
Tengteng Yu, Mu Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuhui Deng, Lanting Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhongqing Li(Guangxi Medical University), Dehui Zou(Chinese Academy of Medical Sciences & Peking Union Medical College), Lugui Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yu‐Tzu Tai(Harvard University), Gang An(RAM Laboratories (United States)), Xiaoke Ma, Kenneth C. Anderson(Dana-Farber Cancer Institute), Леи Жао(Sichuan University), Wen Zhou(Academy of Medical Sciences), Jie Xu(Cornell University), Zhen Yu(Shandong University), Weiwei Sui, Chenxing Du, Fenghuang Zhan(Winthrop Rockefeller Foundation), Xiaojing Wei(Guangzhou University of Chinese Medicine), Guido Tricot
Cited by 0
Related Papers
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k